Kypha raises $4m to expand capabilities of Irish subsidary Biosensia
US company acquired NovaUCD-based biotech firm for an undisclosed sum in July
Dublin-based Biosensia acquired by US company Kypha
NovaUCD-based company has point-of-care in-vitro diagnosis system known as RapiPlex
Biosensia screening test set to speed up diagnosis of head trauma
Diagnostic platform RapiPlex due to arrive on market in about two years’ time
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices